找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Systems and Integrative Biology; Usha N. Kasid,Robert Clarke Book 2023 The Editor(s) (if applicable) and The Author(s), under exclu

[復(fù)制鏈接]
樓主: audiogram
31#
發(fā)表于 2025-3-26 21:22:29 | 只看該作者
Studies in Computational Intelligence (CF) lung epithelial cells using .[S] methionine or .[P] and the consequences of repair by gene therapy with [wildtype] CFTR. This novel antibody microarray-based technology identifies relevant, hidden proteins whose regulation by the CF genotype would never have been detected by simple measurements of total proteomic masses.
32#
發(fā)表于 2025-3-27 01:48:17 | 只看該作者
https://doi.org/10.1007/978-3-319-21569-3onto this therapeutic approach. We envision delivering these molecules by direct injection into solid tumors for the treatment of squamous cell carcinomas of the lung, esophageal cancer, and head and neck cancer. We provide experimental details and methodology for utilizing CRISPR/Cas as a supplement to chemotherapy to destroy lung cancer cells.
33#
發(fā)表于 2025-3-27 06:39:39 | 只看該作者
34#
發(fā)表于 2025-3-27 10:24:25 | 只看該作者
35#
發(fā)表于 2025-3-27 17:12:33 | 只看該作者
Discovery of a Hidden Proinflammatory Signaling Proteome Using a Large-Scale, Targeted Antibody Mic (CF) lung epithelial cells using .[S] methionine or .[P] and the consequences of repair by gene therapy with [wildtype] CFTR. This novel antibody microarray-based technology identifies relevant, hidden proteins whose regulation by the CF genotype would never have been detected by simple measurements of total proteomic masses.
36#
發(fā)表于 2025-3-27 21:13:57 | 只看該作者
37#
發(fā)表于 2025-3-28 01:52:32 | 只看該作者
38#
發(fā)表于 2025-3-28 02:17:30 | 只看該作者
39#
發(fā)表于 2025-3-28 08:45:28 | 只看該作者
40#
發(fā)表于 2025-3-28 13:44:20 | 只看該作者
New Horizons for Asian Museums and Museologyreactive oxygen species, altering the microbiota, and influencing immune responses to cancer cells. Although the focus of this report is cancer metastasis, MNX mice have proven to be valuable in studying mitochondrial contributions to other diseases as well.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-27 05:43
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
塔城市| 伊春市| 陵川县| 八宿县| 南岸区| 镇巴县| 鹤岗市| 灵丘县| 黎川县| 华池县| 澄江县| 宜阳县| 桐城市| 永和县| 贵港市| 嘉兴市| 咸丰县| 唐海县| 额敏县| 文山县| 绥阳县| 哈密市| 汉源县| 古交市| 科尔| 台山市| 荔浦县| 绥滨县| 贵德县| 肥西县| 盈江县| 永安市| 罗城| 博兴县| 奇台县| 丰都县| 朝阳县| 庄浪县| 尼玛县| 儋州市| 关岭|